Congenital Adrenal Hyperplasia Presenting as Pulseless Ventricular Tachycardia in a Neonate.
congenital adrenal hyperplasia
pulseless ventricular tachycardia
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
24 May 2019
24 May 2019
Historique:
entrez:
1
8
2019
pubmed:
1
8
2019
medline:
1
8
2019
Statut:
epublish
Résumé
Congenital adrenal hyperplasia (CAH) comprises a group of autosomal recessive inherited disorders that arise due to defects in one of the enzymes of steroidogenesis pathway in the adrenal glands. Ninety-five percent of the cases occur due to deficiency in 21-hydroxylase (21-OH). Clinically, CAH due to 21-OH deficiency presents in two distinct forms, classic CAH and non-classic CAH. Females with classical forms present with genial ambiguity while the presentation in males is more subtle with severe electrolyte disturbances being the initial manifestation in many cases. Arrhythmias are a rare manifestation of CAH. We report the case of an 18-day-old male child who presented with pulseless ventricular tachycardia and was later diagnosed with congenital adrenal hyperplasia based on the laboratory findings of elevated 17-hydroxyprogesterone (17-OHP) levels. Our case reveals that fatal arrhythmias such as a pulseless ventricular tachycardia can be the primary manifestation of the adrenal insufficiency of CAH even in the absence of any physical findings and hence clinicians should always maintain a strong suspicion for CAH in any child presenting with unexplained arrhythmia. Furthermore, this case also highlights the need for CAH screening in neonates so that the appropriate hormone replacement can be initiated before the development of life-threatening adrenal crisis.
Identifiants
pubmed: 31363431
doi: 10.7759/cureus.4749
pmc: PMC6663285
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e4749Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Pediatr. 1999 Jul;135(1):71-5
pubmed: 10393607
Resuscitation. 2000 Nov;47(3):219-29
pubmed: 11114451
Ann Intern Med. 2002 Feb 19;136(4):320-34
pubmed: 11848730
BMJ. 2002 Jun 1;324(7349):1320-3
pubmed: 12039829
Anaesth Intensive Care. 2002 Jun;30(3):380-1
pubmed: 12075652
N Engl J Med. 2003 Aug 21;349(8):776-88
pubmed: 12930931
Mayo Clin Proc. 2005 Jun;80(6):774-82
pubmed: 15945529
Lancet. 2005 Jun 18-24;365(9477):2125-36
pubmed: 15964450
Pediatr Cardiol. 2005 Sep-Oct;26(5):686-9
pubmed: 16021385
JAMA. 2006 Jan 4;295(1):50-7
pubmed: 16391216
Rev Endocr Metab Disord. 2007 Dec;8(4):349-63
pubmed: 17885806
J Clin Endocrinol Metab. 2010 Sep;95(9):4133-60
pubmed: 20823466
Indian J Pediatr. 2011 Feb;78(2):211-8
pubmed: 20978872
J Pediatr Endocrinol Metab. 2015 May;28(5-6):701-4
pubmed: 25503463
J Pediatr Endocrinol Metab. 2017 Nov 27;30(12):1327-1331
pubmed: 29127765
Pediatrics. 1988 Jun;81(6):866-74
pubmed: 3259306